Instinct Bio Technical Company Holdings Inc. (BIOT) Key Metrics
BIOT valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $6.6M
- Enterprise value
- $11.9M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 10.9
- Price / book
- 5.3
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- —
BIOT key metrics, FY2023–FY2024
Fiscal year ended November 30, 2024 · U.S. dollarsBIOT returns How much profit the business earns on the capital it uses.
BIOT financial health Debt, liquidity and how easily interest is covered.
BIOT efficiency & capital use Working capital cycle and where the cash goes.
BIOT returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
BIOT debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
BIOT key metrics
FY2023–FY2024| FY2024 | FY2023 | |
|---|---|---|
| Returns & profitability | ||
| Return on equity (ROE) | 3.2% | 23.6% |
| Return on invested capital (ROIC) | −2.8% | 15.2% |
| Return on assets (ROA) | 2.3% | 15.9% |
| Return on tangible assets | 2.4% | 16.1% |
| Free cash flow margin | 20.4% | −30.5% |
| Income quality (OCF / net income) | 7.90 | −1.79 |
| Financial health | ||
| Cash & short-term investments | $512,446 | $240,380 |
| Net debt | −$512,446 | −$240,380 |
| Net debt / EBITDA | −1.40 | −0.29 |
| Current ratio | 2.74 | 2.20 |
| Quick ratio | 2.18 | 1.65 |
| Interest coverage | -19.1 | 47.1 |
| Working capital | $1.2M | $1.0M |
| Invested capital | $1.8M | $2.1M |
| Tangible asset value | $2.3M | $2.3M |
| Net current asset value | $1.0M | $788,478 |
| Capital allocation | ||
| Dividends paid | $0 | $0 |
| Dividend payout ratio | 0.0% | 0.0% |
| Dividends + buybacks / free cash flow | 0.0% | — |
| Capex / revenue | 1.0% | 2.0% |
| Capex / operating cash flow | 4.5% | — |
| Capex / depreciation | 0.11 | 0.32 |
| SG&A / revenue | 74.9% | 73.7% |
| Efficiency | ||
| Days sales outstanding | 50.9 | 37.2 |
| Days of inventory on hand | 201.7 | 378.7 |
| Days payables outstanding | 16.3 | 13.3 |
| Cash conversion cycle (days) | 236.3 | 402.6 |
| Receivables turnover | 7.17 | 9.82 |
| Payables turnover | 22.39 | 27.46 |
| Inventory turnover | 1.81 | 0.96 |
| Asset turnover | 0.85 | 1.00 |
| Average receivables | $385,036 | $349,683 |
| Average payables | $34,030 | $16,610 |
| Average inventory | $420,992 | $473,223 |
| Intangibles / total assets | 1.3% | 1.2% |
Computed from BIOT's annual financial statements (latest annual report filed —) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
BIOT valuation and financial ratios
Instinct Bio Technical earned a return on equity of 3.2% and a return on invested capital of −2.8% in fiscal 2024.
See the BIOT income statement, the BIOT chart for price history, or the BIOT stock overview for the latest quote and news.
BIOT key metrics FAQ
What is Instinct Bio Technical's return on equity?
Instinct Bio Technical's return on equity (ROE) was 3.2% in fiscal 2024: net income of $0.1 million on average shareholders' equity of $2.3 million.
What is Instinct Bio Technical's ROIC?
Instinct Bio Technical's return on invested capital was −2.8% in fiscal 2024, using after-tax operating income divided by average debt plus equity minus cash.
Does Instinct Bio Technical pay a dividend?
Instinct Bio Technical did not pay a dividend in fiscal 2024.
What is Instinct Bio Technical's current ratio?
Instinct Bio Technical's current ratio was 2.74 at the end of fiscal 2024: current assets were 2.74 times current liabilities.